Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Lymphoma 178Lymphoma, Large B-Cell, Diffuse 172Precursor Cell Lymphoblastic Leukemia-Lymphoma 88Lymphoma, Follicular 79Lymphoma, Non-Hodgkin 73Burkitt Lymphoma 66Hodgkin Disease 45Leukemia 44Lymphoma, Mantle-Cell 41Lymphoma, T-Cell, Peripheral 31Lymphoma, B-Cell 30Lymphoma, B-Cell, Marginal Zone 28Lymphoma, Large-Cell, Anaplastic 26Lymphoma, Large-Cell, Immunoblastic 24Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 22Leukemia, Lymphocytic, Chronic, B-Cell 22Recurrence 15Immunoblastic Lymphadenopathy 15Neoplasms 14Lymphoma, T-Cell 14Dendritic Cell Sarcoma, Interdigitating 13Waldenstrom Macroglobulinemia 9Multiple Myeloma 9Blast Crisis 8Myelodysplastic Syndromes 7Lymphoma, T-Cell, Cutaneous 7Leukemia, Biphenotypic, Acute 7Enteropathy-Associated T-Cell Lymphoma 7Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 6Neoplasms, Plasma Cell 6

Interventions

Aprepitant 7Ondansetron 5Palonosetron 3Granisetron 3Dexamethasone 3Cyclophosphamide 3Calcium Dobesilate 3Vincristine 2Rituximab 2Doxorubicin 2dexamethasone acetate 1dexamethasone 21-phosphate 1Yoga 1Tropisetron 1Sugars 1R-CHOP protocol 1Prochlorperazine 1Prednisone 1Prednisolone 1Music Therapy 1Metoclopramide 1Lorazepam 1Immunoenzyme Techniques 1Electroacupuncture 1Cyproheptadine 1Antiemetics 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Nausea × Prednisone × Lymphoid × Clear all
NCT00651755 2013-07-02

Aprepitant's Effect on Drug Metabolism in Multi-Day Combination (CHOP/R-CHOP) Chemotherapy Regimen in Lymphoma Patients

M.D. Anderson Cancer Center

Phase NA Completed
23 enrolled 14 charts
Lymphoid

Lymphoma, Lymphoma, Non-Hodgkin, Nausea

Data powered by HemOnc (CC BY 4.0) Colophon âš¡